PART IX DRUG TARIFF INDUSTRY FORUM
10:00 AM - 15:00 PM
The Part IX Industry Drug Tariff Committee was formed in the early 1990s to represent companies supplying medical devices through prescription to the public, as listed in Part IX of the Drug Tariff.
Its mission is to inform and represent the views of those companies, via the Part IX Industry Drug Tariff Forum, to the relevant UK authorities and influence its members to be in compliance with common agreements with those authorities. It recognises the critical role of part IX in the patient pathway and actively supports and promotes this process as the optimal solution to ensuring choice and equity of access to devices for patients, in line with the healthcare aspirations of the UK governments and the societies they serve.
The Committee is comprised of representatives of all the relevant Industry Associations. Currently these are:
ABHI (Association of British Healthcare Industry)
BIVDA (British In-Vitro Diagnostics Association)
BHTA (British Healthcare Trade Association)
SDMA (Surgical Dressings Manufacturers Association)
UTA (Urology Trade Association)
It takes its mandate from all relevant companies, whether they are members of the above Associations or not, via the Part IX Industry Drug Tariff Forum.
Forum meetings are held twice a year, and attendance is open to all companies with an interest in Part IX.
Procurement, Regulatory and International issues are critical to our future success and the association brings enormous value in these key areas.Simon Talbot (Managing Director P3 Medical Ltd )